4.7 Article

Differential gene expression in leiomyosarcoma

Journal

CANCER
Volume 98, Issue 5, Pages 1029-1038

Publisher

JOHN WILEY & SONS INC
DOI: 10.1002/cncr.11586

Keywords

gene expression; microarray; cancer; uterus; myometrium; leiomyosarcoma (LMS); doublecortin; calpain 6; proteolipid 1; interleukin-17B; osteopontin; pituitary tumor transforming; ubiquitin; cyclin-dependent kinase inhibitor 2A; diaphanous; protein regulator of cytokinesis; leiomyoma

Categories

Ask authors/readers for more resources

BACKGROUND. Leiomyosarcomas (LMS) are a common subtype of soft tissue sarcoma. The molecular causes of the disease remain unclear. METHODS. in the current study, gene expression in LMS, leiomyomas, and normal myometrium was examined. RNA was prepared and gene expression was determined using microarray analysis arrays containing approximately 12,000 known genes and 48,000 expressed squence tags (ESTs). RESULTS. A number of genes were found to be differentially expressed in these sample sets, and six genes including cyclin-dependent kinase inhibitor 2A, diaphanous (Drosophila homolog) 3, doublecortin, calpain 6, interleukin-17B, and proteolipid 1 were found to be overexpressed in LMS compared with normal myometrium and 18 other tissues. Sets of genes were identified whose expression could be used to cluster samples with either LMS, leiomyomas, or normal myometrium. CONCLUSIONS. The authors concluded that differences in gene expression can be detected between LMS and leiomyomas, normal myometrium, and other tissues, and that these changes in gene expression may yield clues with regard to the pathophysiology of leiomyosarcoma. (C) 2003 American Cancer Society.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available